Amrize Ltd (NYSE:AMRZ - Get Free Report) insider Stephen Clark bought 5,260 shares of Amrize stock in a transaction dated Tuesday, August 11th. The shares were bought at an average cost of $47.31 per share, with a total value of $248,850.60. Following the completion of the transaction, the insider directly owned 10,637 shares in the company, valued at approximately $503,236.47. This trade represents a 97.82% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.
Amrize Stock Performance
Shares of NYSE:AMRZ traded up $0.28 during mid-day trading on Thursday, reaching $46.65. The company had a trading volume of 1,261,074 shares, compared to its average volume of 3,206,131. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38. The firm has a market cap of $25.80 billion, a price-to-earnings ratio of 21.52, a PEG ratio of 1.02 and a beta of 0.11. The company's 50-day moving average price is $51.50 and its 200-day moving average price is $54.58. Amrize Ltd has a one year low of $46.03 and a one year high of $65.94.
Amrize (NYSE:AMRZ - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.17%. The firm had revenue of $3.50 billion during the quarter. As a group, equities research analysts anticipate that Amrize Ltd will post 2.72 EPS for the current fiscal year.
Amrize Announces Dividend
The company also recently declared a dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 19th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, August 18th. Amrize's dividend payout ratio is currently 20.28%.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on the company. Citigroup lowered their price objective on Amrize from $66.00 to $58.00 and set a "buy" rating on the stock in a research note on Tuesday. Truist Financial reiterated a "hold" rating and issued a $48.00 target price (down from $65.00) on shares of Amrize in a research note on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Amrize in a research report on Friday, June 26th. Morgan Stanley set a $63.00 price target on shares of Amrize and gave the company an "overweight" rating in a research note on Monday, June 22nd. Finally, Weiss Ratings downgraded shares of Amrize from a "hold (c-)" rating to a "sell (d+)" rating in a report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $60.57.
Read Our Latest Research Report on AMRZ
Institutional Trading of Amrize
Institutional investors have recently added to or reduced their stakes in the stock. MCF Advisors LLC purchased a new position in Amrize during the fourth quarter valued at approximately $27,000. Basepoint Wealth LLC purchased a new stake in Amrize in the 4th quarter worth approximately $33,000. Laurel Wealth Advisors LLC bought a new position in Amrize in the 4th quarter valued at $34,000. Itau Unibanco Holding S.A. boosted its holdings in Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company's stock valued at $41,000 after purchasing an additional 450 shares during the period. Finally, US Bancorp DE purchased a new position in shares of Amrize during the 3rd quarter valued at $38,000.
Amrize Company Profile
(
Get Free Report)
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Amrize, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.
While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.